Pneumococcal conjugate second or third-dose vaccines (PCVc) in Bhutan
Bhutan: Pneumococcal conjugate second or third-dose vaccines (PCVc) was 99.0% in 2025. ◆ Volatile
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Bhutan, 2008–2025
Source: World Health Organization, Global Health Observatory.
Analysis
Bhutan recorded 99.0% for pneumococcal conjugate second or third-dose vaccines (pcvc) in 2025. That is the highest value across all 18 years on record.
The figure is up 1.0% on the previous year and up 10.0% over five years.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) in Bhutan peaked at 99.0% in 2023 and was at its lowest, 0.0%, in 2008.
Bhutan ranks 1st of 194 countries on this measure, in the top 10%.
The series is highly variable year to year, so single readings are best treated with caution.
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Bhutan, year by year
| Year | Value | Change |
|---|---|---|
| 2008 | 0.0% | — |
| 2009 | 0.0% | — |
| 2010 | 0.0% | — |
| 2011 | 0.0% | — |
| 2012 | 0.0% | — |
| 2013 | 0.0% | — |
| 2014 | 0.0% | — |
| 2015 | 0.0% | — |
| 2016 | 0.0% | — |
| 2017 | 0.0% | — |
| 2018 | 0.0% | — |
| 2019 | 26.0% | — |
| 2020 | 90.0% | +246.2% |
| 2021 | 95.0% | +5.6% |
| 2022 | 97.0% | +2.1% |
| 2023 | 99.0% | +2.1% |
| 2024 | 98.0% | -1.0% |
| 2025 | 99.0% | +1.0% |
Bhutan compared with similar countries
- Bhutan's 99.0% is above the median for lower middle income countries, which is 84.0%, 1.2× the median. (47 countries reporting)
- Bhutan's 99.0% is above the median for South Asia, which is 94.0%, 1.1× the median. (6 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 2 |
| 2010s | 2.6% | 0.0% | 26.0% | 10 |
| 2020s | 96.3% | 90.0% | 99.0% | 6 |
Countries ranked near Bhutan
More health data for Bhutan
- Un projection of annual infant deaths, annual growth rate -10 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.0915 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,531 deaths per 1,000 people (2090)
- Number of infants who die before age 1 9 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate 0.2986 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0299 units per person (2025)
- Population ages 00-04, male, annual growth rate 0.3987 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) in Bhutan?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) in Bhutan was 99.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Bhutan?
- The highest recorded value was 99.0% in 2023.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Bhutan?
- The lowest recorded value was 0.0% in 2008.
- How does Bhutan rank for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Bhutan ranks 1st out of 194 countries with data for 2025.
- Where does this Bhutan data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).